ID TVB19_HUMAN Reviewed; 114 AA.
AC A0A075B6N1;
DT 23-MAY-2018, integrated into UniProtKB/Swiss-Prot.
DT 29-OCT-2014, sequence version 2.
DT 24-JAN-2024, entry version 55.
DE RecName: Full=T cell receptor beta variable 19 {ECO:0000303|Ref.2};
DE Flags: Precursor;
GN Name=TRBV19 {ECO:0000303|Ref.2};
OS Homo sapiens (Human).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC Homo.
OX NCBI_TaxID=9606;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (IMGT ALLELE TRBV19*01).
RX PubMed=12853948; DOI=10.1038/nature01782;
RA Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA Wilson R.K.;
RT "The DNA sequence of human chromosome 7.";
RL Nature 424:157-164(2003).
RN [2]
RP NOMENCLATURE.
RA Lefranc M.P., Lefranc G.;
RT "The T Cell Receptor FactsBook.";
RL (In) Lefranc M.P., Lefranc G. (eds.);
RL The T Cell Receptor FactsBook., pp.1-397, Academic Press, London. (2001).
RN [3]
RP REVIEW ON T CELL REPERTOIRE DIVERSITY.
RX PubMed=15040585; DOI=10.1038/nri1292;
RA Nikolich-Zugich J., Slifka M.K., Messaoudi I.;
RT "The many important facets of T-cell repertoire diversity.";
RL Nat. Rev. Immunol. 4:123-132(2004).
RN [4]
RP REVIEW ON T CELL RECEPTOR-CD3 COMPLEX ASSEMBLY, AND SUBCELLULAR LOCATION.
RX PubMed=20452950; DOI=10.1101/cshperspect.a005140;
RA Wucherpfennig K.W., Gagnon E., Call M.J., Huseby E.S., Call M.E.;
RT "Structural biology of the T-cell receptor: insights into receptor
RT assembly, ligand recognition, and initiation of signaling.";
RL Cold Spring Harb. Perspect. Biol. 2:A005140-A005140(2010).
RN [5]
RP REVIEW ON T CELL RECEPTOR SIGNALING.
RX PubMed=23524462; DOI=10.1038/nri3403;
RA Brownlie R.J., Zamoyska R.;
RT "T cell receptor signalling networks: branched, diversified and bounded.";
RL Nat. Rev. Immunol. 13:257-269(2013).
RN [6]
RP NOMENCLATURE.
RX PubMed=24600447; DOI=10.3389/fimmu.2014.00022;
RA Lefranc M.P.;
RT "Immunoglobulin and T Cell Receptor Genes: IMGT((R)) and the Birth and Rise
RT of Immunoinformatics.";
RL Front. Immunol. 5:22-22(2014).
RN [7]
RP INTERACTION WITH STAPHYLOCOCCUS AUREUS ENTEROTOXIN TYPE B/SEB (MICROBIAL
RP INFECTION).
RX PubMed=25015819; DOI=10.4049/jimmunol.1401268;
RA Rodstrom K.E., Elbing K., Lindkvist-Petersson K.;
RT "Structure of the superantigen staphylococcal enterotoxin B in complex with
RT TCR and peptide-MHC demonstrates absence of TCR-peptide contacts.";
RL J. Immunol. 193:1998-2004(2014).
RN [8]
RP REVIEW ON FUNCTION.
RX PubMed=25493333; DOI=10.1146/annurev-immunol-032414-112334;
RA Rossjohn J., Gras S., Miles J.J., Turner S.J., Godfrey D.I., McCluskey J.;
RT "T cell antigen receptor recognition of antigen-presenting molecules.";
RL Annu. Rev. Immunol. 33:169-200(2015).
RN [9] {ECO:0007744|PDB:5HHM, ECO:0007744|PDB:5HHO}
RP X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 21-113, AND DISULFIDE BONDS.
RX PubMed=27036003; DOI=10.1073/pnas.1603106113;
RA Valkenburg S.A., Josephs T.M., Clemens E.B., Grant E.J., Nguyen T.H.,
RA Wang G.C., Price D.A., Miller A., Tong S.Y., Thomas P.G., Doherty P.C.,
RA Rossjohn J., Gras S., Kedzierska K.;
RT "Molecular basis for universal HLA-A*0201-restricted CD8+ T-cell immunity
RT against influenza viruses.";
RL Proc. Natl. Acad. Sci. U.S.A. 113:4440-4445(2016).
CC -!- FUNCTION: V region of the variable domain of T cell receptor (TR) beta
CC chain that participates in the antigen recognition (PubMed:24600447).
CC Alpha-beta T cell receptors are antigen specific receptors which are
CC essential to the immune response and are present on the cell surface of
CC T lymphocytes. Recognize peptide-major histocompatibility (MH) (pMH)
CC complexes that are displayed by antigen presenting cells (APC), a
CC prerequisite for efficient T cell adaptive immunity against pathogens
CC (PubMed:25493333). Binding of alpha-beta TR to pMH complex initiates
CC TR-CD3 clustering on the cell surface and intracellular activation of
CC LCK that phosphorylates the ITAM motifs of CD3G, CD3D, CD3E and CD247
CC enabling the recruitment of ZAP70. In turn ZAP70 phosphorylates LAT,
CC which recruits numerous signaling molecules to form the LAT
CC signalosome. The LAT signalosome propagates signal branching to three
CC major signaling pathways, the calcium, the mitogen-activated protein
CC kinase (MAPK) kinase and the nuclear factor NF-kappa-B (NF-kB)
CC pathways, leading to the mobilization of transcription factors that are
CC critical for gene expression and essential for T cell growth and
CC differentiation (PubMed:23524462). The T cell repertoire is generated
CC in the thymus, by V-(D)-J rearrangement. This repertoire is then shaped
CC by intrathymic selection events to generate a peripheral T cell pool of
CC self-MH restricted, non-autoaggressive T cells. Post-thymic interaction
CC of alpha-beta TR with the pMH complexes shapes TR structural and
CC functional avidity (PubMed:15040585). {ECO:0000303|PubMed:15040585,
CC ECO:0000303|PubMed:23524462, ECO:0000303|PubMed:24600447,
CC ECO:0000303|PubMed:25493333}.
CC -!- SUBUNIT: Alpha-beta TR is a heterodimer composed of an alpha and beta
CC chain; disulfide-linked. The alpha-beta TR is associated with the
CC transmembrane signaling CD3 coreceptor proteins to form the TR-CD3 (TcR
CC or TCR). The assembly of alpha-beta TR heterodimers with CD3 occurs in
CC the endoplasmic reticulum where a single alpha-beta TR heterodimer
CC associates with one CD3D-CD3E heterodimer, one CD3G-CD3E heterodimer
CC and one CD247 homodimer forming a stable octameric structure. CD3D-CD3E
CC and CD3G-CD3E heterodimers preferentially associate with TR alpha and
CC TR beta chains, respectively. The association of the CD247 homodimer is
CC the last step of TcR assembly in the endoplasmic reticulum and is
CC required for transport to the cell surface.
CC {ECO:0000303|PubMed:20452950}.
CC -!- SUBUNIT: (Microbial infection) Interacts with Staphylococcus aureus
CC enterotoxin type B/SEB. {ECO:0000269|PubMed:25015819}.
CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000303|PubMed:20452950}.
CC -!- POLYMORPHISM: There are several alleles. The sequence shown is that of
CC IMGT allele TRBV19*01. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AC244472; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR PDB; 5HHM; X-ray; 2.50 A; E/J=21-113.
DR PDB; 5HHO; X-ray; 2.95 A; E=21-114.
DR PDB; 5NQK; X-ray; 3.25 A; B=22-113.
DR PDBsum; 5HHM; -.
DR PDBsum; 5HHO; -.
DR PDBsum; 5NQK; -.
DR AlphaFoldDB; A0A075B6N1; -.
DR SMR; A0A075B6N1; -.
DR IMGT_GENE-DB; TRBV19; -.
DR GlyCosmos; A0A075B6N1; 1 site, No reported glycans.
DR GlyGen; A0A075B6N1; 1 site.
DR BioMuta; TRBV19; -.
DR MassIVE; A0A075B6N1; -.
DR PeptideAtlas; A0A075B6N1; -.
DR Ensembl; ENST00000390393.3; ENSP00000374916.3; ENSG00000211746.3.
DR UCSC; uc003vzo.4; human.
DR AGR; HGNC:12194; -.
DR GeneCards; TRBV19; -.
DR HGNC; HGNC:12194; TRBV19.
DR HPA; ENSG00000211746; Tissue enriched (lymphoid).
DR neXtProt; NX_A0A075B6N1; -.
DR OpenTargets; ENSG00000211746; -.
DR VEuPathDB; HostDB:ENSG00000211746; -.
DR GeneTree; ENSGT00940000163545; -.
DR HOGENOM; CLU_077975_9_2_1; -.
DR InParanoid; A0A075B6N1; -.
DR OMA; VHKCAQS; -.
DR ChiTaRS; TRBV19; human.
DR Pharos; A0A075B6N1; Tdark.
DR PRO; PR:A0A075B6N1; -.
DR Proteomes; UP000005640; Chromosome 7.
DR RNAct; A0A075B6N1; Protein.
DR Bgee; ENSG00000211746; Expressed in lymph node and 77 other cell types or tissues.
DR GO; GO:0042105; C:alpha-beta T cell receptor complex; IDA:UniProtKB.
DR GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR GO; GO:0007166; P:cell surface receptor signaling pathway; IBA:GO_Central.
DR Gene3D; 2.60.40.10; Immunoglobulins; 1.
DR InterPro; IPR007110; Ig-like_dom.
DR InterPro; IPR036179; Ig-like_dom_sf.
DR InterPro; IPR013783; Ig-like_fold.
DR InterPro; IPR013106; Ig_V-set.
DR PANTHER; PTHR23268:SF28; T CELL RECEPTOR BETA VARIABLE 19; 1.
DR PANTHER; PTHR23268; T-CELL RECEPTOR BETA CHAIN; 1.
DR Pfam; PF07686; V-set; 1.
DR SMART; SM00406; IGv; 1.
DR SUPFAM; SSF48726; Immunoglobulin; 1.
DR PROSITE; PS50835; IG_LIKE; 1.
PE 1: Evidence at protein level;
KW 3D-structure; Adaptive immunity; Cell membrane; Disulfide bond;
KW Glycoprotein; Immunity; Immunoglobulin domain; Membrane; Receptor;
KW Reference proteome; Signal; T cell receptor.
FT SIGNAL 1..21
FT /evidence="ECO:0000255"
FT CHAIN 22..114
FT /note="T cell receptor beta variable 19"
FT /evidence="ECO:0000255"
FT /id="PRO_5001705258"
FT DOMAIN 22..>114
FT /note="Ig-like"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT CARBOHYD 37
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT DISULFID 42..110
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT ECO:0000269|PubMed:27036003, ECO:0007744|PDB:5HHM,
FT ECO:0007744|PDB:5HHO"
FT NON_TER 114
FT STRAND 23..26
FT /evidence="ECO:0007829|PDB:5HHO"
FT STRAND 28..33
FT /evidence="ECO:0007829|PDB:5HHM"
FT STRAND 38..40
FT /evidence="ECO:0007829|PDB:5HHM"
FT STRAND 49..56
FT /evidence="ECO:0007829|PDB:5HHM"
FT STRAND 63..70
FT /evidence="ECO:0007829|PDB:5HHM"
FT STRAND 73..76
FT /evidence="ECO:0007829|PDB:5HHM"
FT STRAND 83..85
FT /evidence="ECO:0007829|PDB:5HHM"
FT STRAND 88..92
FT /evidence="ECO:0007829|PDB:5HHO"
FT STRAND 95..97
FT /evidence="ECO:0007829|PDB:5HHM"
FT STRAND 106..113
FT /evidence="ECO:0007829|PDB:5HHM"
SQ SEQUENCE 114 AA; 12769 MW; BC3114AD0BB6BB3C CRC64;
MSNQVLCCVV LCLLGANTVD GGITQSPKYL FRKEGQNVTL SCEQNLNHDA MYWYRQDPGQ
GLRLIYYSQI VNDFQKGDIA EGYSVSREKK ESFPLTVTSA QKNPTAFYLC ASSI
//
